Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Nakamura

Showing results (1-10 of 769) with videos related to

Pageof 77
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 11, 2004
[Therapeutic guidelines for acute coronary syndrome]Masato Nakamura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2015
[Reception and adjuvant chemotherapy for metastatic site of colorectal cancer]Masato Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 26, 2012
[Invasive treatment strategy and the timing of invasive therapy for acute coronary syndromes]Masato Nakamura
Circulation Journal : Official Journal of the Japanese Circulation Society|March 11, 2011
The door is open and the next step is forthcoming--lesson from J-SMART registryMasato Nakamura
Nihon Hoshasen Gijutsu Gakkai Zasshi|September 19, 2022
[Cybersecurity Issues in Medical Institutions]Masato Nakamura
Journal of Atherosclerosis and Thrombosis|August 30, 2019
What is the Sweet Spot for Platelet Reactivity in Japanese Patients?Masato Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 11, 2011
[Endovascular treatment for renal artery stenosis]Masato Nakamura
Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2010
Angiography is the gold standard and objective evidence of myocardial ischemia is mandatory if lesion severity is questionable. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Pro)-Masato Nakamura
Nihon Hoshasen Gijutsu Gakkai Zasshi|May 14, 2003
[Cardiac imaging of ischemic heart disease]Masato Nakamura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 6, 2018
[Evidence Based Secondary Prevention of Ischemic Heart Disease. Topics: I. Advances and Evidence of Pharmacotherapy: 2. Up to Date Lipid Lowering Treatment]Masato Nakamura
Pageof 77

Showing results (1-10 of 769) with videos related to

Sort By:
Pageof 77
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 11, 2004
[Therapeutic guidelines for acute coronary syndrome]Masato Nakamura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 13, 2015
[Reception and adjuvant chemotherapy for metastatic site of colorectal cancer]Masato Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 26, 2012
[Invasive treatment strategy and the timing of invasive therapy for acute coronary syndromes]Masato Nakamura
Circulation Journal : Official Journal of the Japanese Circulation Society|March 11, 2011
The door is open and the next step is forthcoming--lesson from J-SMART registryMasato Nakamura
Nihon Hoshasen Gijutsu Gakkai Zasshi|September 19, 2022
[Cybersecurity Issues in Medical Institutions]Masato Nakamura
Journal of Atherosclerosis and Thrombosis|August 30, 2019
What is the Sweet Spot for Platelet Reactivity in Japanese Patients?Masato Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 11, 2011
[Endovascular treatment for renal artery stenosis]Masato Nakamura
Circulation Journal : Official Journal of the Japanese Circulation Society|December 22, 2010
Angiography is the gold standard and objective evidence of myocardial ischemia is mandatory if lesion severity is questionable. - Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Pro)-Masato Nakamura
Nihon Hoshasen Gijutsu Gakkai Zasshi|May 14, 2003
[Cardiac imaging of ischemic heart disease]Masato Nakamura
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 6, 2018
[Evidence Based Secondary Prevention of Ischemic Heart Disease. Topics: I. Advances and Evidence of Pharmacotherapy: 2. Up to Date Lipid Lowering Treatment]Masato Nakamura
Pageof 77